Literature DB >> 12822295

Public health dispatch: outbreaks of community-associated methicillin-resistant Staphylococcus aureus skin infections--Los Angeles County, California, 2002-2003.

.   

Abstract

Entities:  

Mesh：

Year:  2003        PMID： 12822295

Source DB:  PubMed          Journal:  Can Commun Dis Rep        ISSN： 1188-4169


× No keyword cloud information.
  5 in total

1.  Synthetic Antibacterial Peptide Exhibits Synergy with Oxacillin against MRSA.

Authors:  John C Lainson; Seth M Daly; Kathleen Triplett; Stephen Albert Johnston; Pamela R Hall; Chris W Diehnelt
Journal:  ACS Med Chem Lett       Date:  2017-07-07       Impact factor: 4.345

2.  Innate Sex Bias of Staphylococcus aureus Skin Infection Is Driven by α-Hemolysin.

Authors:  Moriah J Castleman; Srijana Pokhrel; Kathleen D Triplett; Donna F Kusewitt; Bradley O Elmore; Jason A Joyner; Jon K Femling; Geetanjali Sharma; Helen J Hathaway; Eric R Prossnitz; Pamela R Hall
Journal:  J Immunol       Date:  2017-12-08       Impact factor: 5.422

3.  Complement Receptor 3 Contributes to the Sexual Dimorphism in Neutrophil Killing of Staphylococcus aureus.

Authors:  Srijana Pokhrel; Kathleen D Triplett; Seth M Daly; Jason A Joyner; Geetanjali Sharma; Helen J Hathaway; Eric R Prossnitz; Pamela R Hall
Journal:  J Immunol       Date:  2020-08-07       Impact factor: 5.422

4.  VLP-based vaccine induces immune control of Staphylococcus aureus virulence regulation.

Authors:  Seth M Daly; Jason A Joyner; Kathleen D Triplett; Bradley O Elmore; Srijana Pokhrel; Kathryn M Frietze; David S Peabody; Bryce Chackerian; Pamela R Hall
Journal:  Sci Rep       Date:  2017-04-04       Impact factor: 4.379

5.  GPER activation protects against epithelial barrier disruption by Staphylococcus aureus α-toxin.

Authors:  Kathleen D Triplett; Srijana Pokhrel; Moriah J Castleman; Seth M Daly; Bradley O Elmore; Jason A Joyner; Geetanjali Sharma; Guy Herbert; Matthew J Campen; Helen J Hathaway; Eric R Prossnitz; Pamela R Hall
Journal:  Sci Rep       Date:  2019-02-04       Impact factor: 4.379
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.